Skip to main content
. 2022 Feb 10;107(9):2064–2071. doi: 10.3324/haematol.2021.280433

Table 1.

Patients’ characteristics at the time-point of relapsed/refractory acute lymphoblastic leukemia and extramedullary disease.

graphic file with name 1072064.tab1.jpg